Therapeutic Areas
8,621+
FDA Drugs
33,623
Active Trials
19
Therapeutic Areas
🧬
Oncology
+96 since 2024 694 drugs
22,278 trials
40 indications
Solid Tumor (Advanced), Breast Cancer, Non-Hodgkin Lymphoma ...
Leaders: Pfizer, Novartis, HIKMA
🧠
CNS
+40 since 2024 867 drugs
2,207 trials
18 indications
Major Depression, Alzheimer's Disease, Schizophrenia ...
Leaders: AbbVie, Novartis, HIKMA
❤️
Cardiovascular
+33 since 2024 1,020 drugs
1,488 trials
9 indications
Hypertension, Heart Failure, Stroke ...
Leaders: B BRAUN, Pfizer, BAXTER HLTHCARE
⚗️
Metabolic
+23 since 2024 345 drugs
1,453 trials
7 indications
Type 2 Diabetes, Obesity, Diabetes (General) ...
Leaders: Eli Lilly, Novartis, NOVO NORDISK INC
🛡️
Immunology
+30 since 2024 398 drugs
1,426 trials
15 indications
Rheumatoid Arthritis, Psoriasis, Atopic Dermatitis ...
Leaders: Pfizer, Novartis, AbbVie
🦠
Infectious Disease
+28 since 2024 1,157 drugs
1,200 trials
13 indications
HIV, COVID-19, Influenza ...
Leaders: Pfizer, GSK, APOTHECON
💊
Pain
+9 since 2024 512 drugs
722 trials
4 indications
Acute Pain, Postoperative Pain, Neuropathic Pain ...
Leaders: HIKMA, HALEON US HOLDINGS, Pfizer
🫁
Respiratory
+14 since 2024 434 drugs
642 trials
7 indications
Asthma, COPD, Pneumonia ...
Leaders: Pfizer, Novartis, GSK
🧩
Rare Disease
+22 since 2024 130 drugs
443 trials
9 indications
Sickle Cell Disease, Immune Thrombocytopenia, Hemophilia ...
Leaders: GENZYME CORP, FERRING PHARMS INC, Sanofi
🦴
Musculoskeletal
+3 since 2024 65 drugs
317 trials
4 indications
Osteoarthritis, Osteoporosis, Gout ...
Leaders: Novartis, Sanofi, ACCORD BIOPHARMA INC.
👁️
Ophthalmology
+12 since 2024 309 drugs
271 trials
3 indications
Age-Related Macular Degeneration, Glaucoma, Dry Eye
Leaders: AbbVie, Novartis, BAUSCH AND LOMB
🫘
Renal
+5 since 2024 120 drugs
241 trials
2 indications
Chronic Kidney Disease, Acute Kidney Injury
Leaders: VANTIVE US HLTHCARE, FRESENIUS MEDCL, B BRAUN
🫃
Gastrointestinal
+5 since 2024 265 drugs
223 trials
5 indications
Nausea/Vomiting, Peptic Ulcer, Constipation ...
Leaders: Pfizer, Novartis, GSK
♀️
Women's Health
+7 since 2024 501 drugs
187 trials
5 indications
Infertility, PCOS, Menopause ...
Leaders: BARR, AUROBINDO PHARMA, XIROMED
🧴
Dermatology
+6 since 2024 288 drugs
177 trials
5 indications
Acne, Alopecia, Rosacea ...
Leaders: BAUSCH, GALDERMA LABS LP, Pfizer
🫀
Hepatology
+4 since 2024 46 drugs
119 trials
2 indications
Cirrhosis, Liver Failure
Leaders: AKARX INC, IPSEN, MIRUM
🚻
Urology
+5 since 2024 81 drugs
108 trials
3 indications
Overactive Bladder, Erectile Dysfunction, Benign Prostatic Hyperplasia
Leaders: AbbVie, Pfizer, MACLEODS PHARMS LTD
😴
Sleep
40 drugs
77 trials
2 indications
Insomnia, Narcolepsy
Leaders: Pfizer, VANDA PHARMS INC, COSETTE
⚖️
Endocrine
+5 since 2024 154 drugs
44 trials
5 indications
Growth Hormone Deficiency, Acromegaly, Hypothyroidism ...
Leaders: Novartis, AbbVie, ENDO OPERATIONS
Drug counts based on FDA-approved products with known therapeutic area classification.
Trial counts from ClinicalTrials.gov active studies.